Education
About Us
Working with TipRanks
Follow Us
MindWalk Holdings (HYFT)
NASDAQ:HYFT
HYFT Stock Chart & Stats
$1.80
--
Market closed
$1.80
--
Day’s Range― - ―
52-Week Range$0.27 - $3.25
Previous CloseN/A
VolumeN/A
Average Volume (3M)523.26K
Market Cap
$93.85M
Enterprise Value$100.56M
Total Cash (Recent Filing)$16.51M
Total Debt (Recent Filing)$3.63M
Price to Earnings (P/E)―
Beta1.91
Next Earnings
Mar 18, 2026EPS Estimate
-0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding46,691,280
10 Day Avg. Volume441,917
30 Day Avg. Volume523,256
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)0.85
Price to Sales (P/S)0.83
P/FCF Ratio-2.80
Enterprise Value/Market Cap1.07
Enterprise Value/Revenue4.90
Enterprise Value/Gross Profit8.96
Enterprise Value/Ebitda-3.22
Forecast
1Y Price Target
$5.00Price Target Upside177.78% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.18
Revenue Forecast (FY)$12.55M
Bulls Say, Bears Say
Bulls Say
Funding StrategyCreation of Cayman Islands-based segregated portfolios to finance individual AI-discovered candidates allows non-dilutive, investor-specific funding for pipeline programs and improves capital flexibility for development.
Revenue Model TransitionManagement's shift toward recurring, subscription-style revenue from industry partners could create more predictable cash flow and reduce dependence on one-time upfront payments.
Vaccine InnovationAnalyst's Buy recommendation follows identification of a conserved influenza target using HYFT Deep Data, enabling development of a broadly protective vaccine that could reduce reliance on strain-specific shots.
Bears Say
Competitive PressureIntense competition from established vaccine manufacturers and alternative technologies may limit market uptake and compress potential pricing for any approved product.
Execution RiskCommercial challenges and execution failures could delay clinical progress and hinder the company's ability to bring vaccine candidates to market.
Legal And Intellectual Property RiskPotential legal disputes or intellectual property conflicts could lead to costly litigation or licensing constraints that limit development and partnering options.
MindWalk Holdings News
HYFT FAQ
What was MindWalk Holdings’s price range in the past 12 months?
MindWalk Holdings lowest stock price was $0.27 and its highest was $3.25 in the past 12 months.
What is MindWalk Holdings’s market cap?
MindWalk Holdings’s market cap is $93.85M.
When is MindWalk Holdings’s upcoming earnings report date?
MindWalk Holdings’s upcoming earnings report date is Mar 18, 2026 which is in 46 days.
How were MindWalk Holdings’s earnings last quarter?
MindWalk Holdings released its earnings results on Dec 15, 2025. The company reported -$0.05 earnings per share for the quarter, missing the consensus estimate of -$0.036 by -$0.014.
Is MindWalk Holdings overvalued?
According to Wall Street analysts MindWalk Holdings’s price is currently Undervalued.
Does MindWalk Holdings pay dividends?
MindWalk Holdings does not currently pay dividends.
What is MindWalk Holdings’s EPS estimate?
MindWalk Holdings’s EPS estimate is -0.04.
How many shares outstanding does MindWalk Holdings have?
MindWalk Holdings has 46,691,280 shares outstanding.
What happened to MindWalk Holdings’s price movement after its last earnings report?
MindWalk Holdings reported an EPS of -$0.05 in its last earnings report, missing expectations of -$0.036. Following the earnings report the stock price went up 1.13%.
Which hedge fund is a major shareholder of MindWalk Holdings?
Currently, no hedge funds are holding shares in HYFT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
MindWalk Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.00 (177.78% Upside)
$5.00 (177.78% Upside)
Blogger Sentiment
Bullish
HYFT Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 7.4%
Last 30 Days ▼ 7.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
291.30%
12-Months-Change
Fundamentals
Return on Equity
-121.76%
Trailing 12-Months
Asset Growth
-56.69%
Trailing 12-Months
Company Description
MindWalk Holdings
MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.
HYFT Company Deck
HYFT Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presents a generally positive outlook for MindWalk, with significant revenue growth, improved gross profit margins, and strategic initiatives like the divestiture of noncore operations and the launch of BioNative AI and HYFT technology. While there are challenges such as operating and net losses, the company's strong cash position and strategic focus on AI-driven R&D suggest a promising future.View all HYFT earnings summariesHYFT Stock 12 Month Forecast
Average Price Target
$5.00
▲(177.78% Upside)
Technical Analysis
XBiotech
―
Relmada Therapeutics
―
PMV Pharmaceuticals
―
Werewolf Therapeutics
―
Estrella Immunopharma
―